Kesh, Kousik
Garrido, Vanessa T.
Dosch, Austin
Durden, Brittany
Gupta, Vineet K.
Sharma, Nikita S. http://orcid.org/0000-0003-3528-1634
Lyle, Michael
Nagathihalli, Nagaraj
Merchant, Nipun
Saluja, Ashok
Banerjee, Sulagna http://orcid.org/0000-0003-2338-1662
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (CA184274, R01-CA124723, CA161976)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
Florida Department of Health (9JK09)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
Pancreatic Cancer Action Network
Article History
Received: 4 May 2020
Revised: 26 October 2020
Accepted: 27 October 2020
First Online: 11 November 2020
Conflict of interest
: University of Minnesota has a patent for Minnelide, which has been licensed to Minneamrita Therapeutics, LLC. A.K.S. is the co-founder and the Chief Scientific Officer of this company. S.B. is a consultant with Minneamrita Therapeutics LLC and this relationship is managed by the University of Miami. The remaining authors declare no conflict of interest.